Synthon-Bagó is a leading company in the treatment of patients with Multiple Sclerosis and other low incidence disabilities, providing the patient with highest-quality products.
It is supported by the knowledge and experience of two leading business groups in the pharmaceutical sector, such as: Synthon Holding and Grupo Bagó.